Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.46
0.00 (0.09%)
Jul 10, 2025, 4:00 PM - Market closed
Third Harmonic Bio Employees
Third Harmonic Bio had 53 employees as of December 31, 2024. The number of employees increased by 23 or 76.67% compared to the previous year.
Employees
53
Change (1Y)
23
Growth (1Y)
76.67%
Revenue / Employee
n/a
Profits / Employee
-$1,008,434
Market Cap
245.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53 | 23 | 76.67% |
| Dec 31, 2023 | 30 | 2 | 7.14% |
| Dec 31, 2022 | 28 | 16 | 133.33% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
THRD News
- 4 weeks ago - Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335 - GlobeNewsWire
- 3 months ago - Third Harmonic Bio Announces Plan of Liquidation and Dissolution - GlobeNewsWire
- 3 months ago - Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 5 months ago - Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape - Benzinga
- 5 months ago - Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update - GlobeNewsWire
- 8 months ago - Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - GlobeNewsWire
- 8 months ago - Third Harmonic Bio to Participate in Upcoming Investor Conferences in November - GlobeNewsWire
- 8 months ago - Third Harmonic Bio Announces Third Quarter 2024 Financial Results - GlobeNewsWire